Lung Cancer Breast Cancer Immunotherapy Early Detection Skin Cancer Cancer Detection Brain Cancer Pancreatic Cancer Chemotherapy Prostate Cancer Colorectal Cancer Vaccines Glioblastoma AI in Medicine Melanoma Cancer Treatment Cachexia Liver Cancer Bladder Cancer Endometrial Cancer Melanoma Treatments Diagnostic Tools HPV-related Cancers Acute Myeloid Leukemia Oral Cancer Pediatric Health Brain Tumors mRNA Vaccines Cancer Metastasis Cancer Prevention Treatment Challenges Neuro-oncology Genetic Interactions Childhood Cancer Diagnostic Methods Tumor Growth Treatment AI in Healthcare Tumor Biology Cancer Vaccines Cancer Biology Obesity-related Cancers Multiple Myeloma Nanomedicine Cognitive Impairment Innovative Treatments Leukaemia Bowel Cancer Palliative Care Myelodysplastic Syndromes
Want to see what podcasts are saying about this topic? Search across 120K+ podcasts. Explore Radar
The June 29 Nature Immunology paper identifies galectin-9 and the IL-33 receptor as drivers of lung inflammation whose blockade halted leukemic entry in experiments.
